U of T’s T-CAIREM, FACIT partner to build ON biotechnology companies

The University of Toronto’s Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM) and FACIT have launched a partnership to commercialize AI innovations and support the next generation of Ontario’s biotechnology companies. The MOU outlines principles that will guide the partnership as it seeks to accelerate the benefits of AI research to benefit patients with cancer. The partners will work together on periodic reviews of T-CAIREM’s novel intellectual property to identify areas for investment, clinical trial engagement, and pilot deployment. FACIT will also guide T-CAIREM scientists on research, market pull strategies, and AI company building; and T-CAIREM scientists will be able to apply for venture seed funding through FACIT’s Compass Rose Oncology Fund.